CBS NewsAstraZeneca pauses COVID-19 vaccine trial over possible adverse reaction in participantSep 9, 2020Jordan FreimanBy Jordan Freimanmore_vert
NBC NewsOxford vaccine trial on hold because of potential safety issueSep 9, 2020Erika Edwards & Sara G. MillerBy Erika Edwards & Sara G. Millermore_vert
The ConversationPutting our money on two COVID vaccines is better than one: why Australia's latest vaccine deal makes senseSep 8, 2020Kylie M. QuinnBy Kylie M. Quinnmore_vert
STATAstraZeneca CEO says participant had neurological symptoms, could be discharged todaySep 9, 2020Adam FeuersteinBy Adam Feuersteinmore_vert
The New York TimesSafety Review Begins Into AstraZeneca's Coronavirus Vaccine TrialNov 25, 2020Katherine J. WuBy Katherine J. Wumore_vert
POLITICOInside Oxford's Vaccine Saga: From Wild Hype to Sobering RealitySep 11, 2020Elizabeth RalphBy Elizabeth Ralphmore_vert
BloombergOxford Vaccine: AstraZeneca Pauses Trial After Unexplained IllnessSep 8, 2020Michelle Cortez & Riley Ray GriffinBy Michelle Cortez & Riley Ray Griffinmore_vert
The GuardianOxford University Covid vaccine trial put on hold due to possible adverse reaction in participantSep 9, 2020Elias VisontayBy Elias Visontaymore_vert
BBC.comCoronavirus: Oxford University vaccine trial paused after participant falls illSep 9, 2020more_vert
STATAstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.Sep 8, 2020Rebecca Robbins, Helen Branswell & Adam FeuersteinBy Rebecca Robbins, Helen Branswell & Adam Feuersteinmore_vert
The New York TimesAstraZeneca Pauses Vaccine Trial for Safety ReviewDec 17, 2020Katie Thomas & Katherine J. WuBy Katie Thomas & Katherine J. Wumore_vert